Feasibility of high-dose interferon-alpha2b adjuvant therapy for high-risk resected cutaneous melanoma. - Muggiano,A.; Mulas,C.; Fiori,B.; Liciardi,G.; Pintus,M.; Tanca,L.; Tedde,A.; Turno,R.; Desogus,A. (Melanoma Res, 2004)